Bausch Health Companies (BHC) Net Cash Flow (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Net Cash Flow came in at -$9.0 million in Q1 2026, up 86.15% year-on-year from -$4.8 million in Q1 2025, and up 59.09% quarter-over-quarter from -$22.0 million in Q4 2025.
Bausch Health Companies (BHC) Net Cash Flow (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Net Cash Flow across 18 years of filings, most recently posting -$9.0 million for Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$9.0 million, up 86.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $119.0 million (down 71.12% YoY), and the FY2025 annual result was $63.0 million, down 77.09% from the prior year.
- Net Cash Flow came in at -$9.0 million for Q1 2026 at Bausch Health Companies, up from -$22.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $547.0 million in Q2 2025 to a low of -$1.4 billion in Q3 2022.
- The 5-year median for Net Cash Flow is -$9.0 million (2026), against an average of -$47.9 million.
- Across the five-year window, Net Cash Flow tumbled 26940.0% in 2022 and jumped 544.72% in 2025, its largest moves.
- Bausch Health Companies' Net Cash Flow stood at $63.0 million in 2022, then surged by 158.73% to $163.0 million in 2023, then surged by 198.16% to $486.0 million in 2024, then sank by 104.53% to -$22.0 million in 2025, then soared by 59.09% to -$9.0 million in 2026.
- The last three Net Cash Flow figures came in at -$9.0 million (Q1 2026), -$22.0 million (Q4 2025), and -$397.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | -9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.00 Mn |
| Mar 31, 2026 | -9.00 Mn |
| Dec 31, 2025 | -22.00 Mn |
| Dec 31, 2025 | -22.00 Mn |
| Sep 30, 2025 | -397.00 Mn |
| Sep 30, 2025 | -397.00 Mn |
| Jun 30, 2025 | 547.00 Mn |
| Jun 30, 2025 | 547.00 Mn |
| Mar 31, 2025 | -65.00 Mn |
| Mar 31, 2025 | -65.00 Mn |
| Dec 31, 2024 | 486.00 Mn |
| Dec 31, 2024 | 486.00 Mn |
| Sep 30, 2024 | 114.00 Mn |
| Sep 30, 2024 | 114.00 Mn |
| Jun 30, 2024 | -123.00 Mn |
| Jun 30, 2024 | -123.00 Mn |
| Mar 31, 2024 | -202.00 Mn |
| Mar 31, 2024 | -202.00 Mn |
| Dec 31, 2023 | 163.00 Mn |
| Dec 31, 2023 | 163.00 Mn |